Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes

EH Morrato, JW Newcomer, S Kamat, O Baser… - Diabetes …, 2009 - Am Diabetes Assoc
OBJECTIVE Several second-generation antipsychotic (SGA) drugs have been associated
with weight gain, hyperglycemia, and dyslipidemia. We evaluated whether glucose and lipid …
被引用次数：242 相关文章

Metabolic Screening After the American Diabetes Association's Consensus Statement on Antipsychotic Drugs and Diabetes.

EH Morrato, JW Newcomer, S Kamat, O Baser… - Diabetes …, 2009 - search.ebscohost.com
OBJECTIVE--Several second-generation antipsychotic (SGA) drugs have been associated
with weight gain, hyperglycemia, and dyslipidemia. We evaluated whether glucose and lipid …

[引用][C] Metabolic Screening After the American Diabetes Association's Consensus Statement on Antipsychotic Drugs and Diabetes

EH MORRATO, JW NEWCOMER, S KAMAT… - Diabetes …, 2009 - pascal-francis.inist.fr
Metabolic Screening After the American Diabetes Association's Consensus Statement on
Antipsychotic Drugs and Diabetes CNRS Inist Pascal-Francis CNRS Pascal and Francis …
[PDF] researchgate.net

[PDF][PDF] Metabolic Screening After the American Diabetes Association's Consensus Statement on Antipsychotic Drugs and Diabetes

EH MORRATO, JW NEWCOMER, S KAMAT… - Diabetes …, 2009 - researchgate.net
OBJECTIVE—Several second-generation antipsychotic (SGA) drugs have been associated
with weight gain, hyperglycemia, and dyslipidemia. We evaluated whether glucose and lipid …

Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes.

EH Morrato, JW Newcomer, S Kamat, O Baser… - Diabetes …, 2009 - europepmc.org
Objective Several second-generation antipsychotic (SGA) drugs have been associated with
weight gain, hyperglycemia, and dyslipidemia. We evaluated whether glucose and lipid …

Metabolic screening after the American diabetes association's consensus statement on antipsychotic drugs and diabetes.

EH Morrato, JW Newcomer, S Kamat, O Baser… - 2009 - cabidigitallibrary.org
Objective: Several second-generation antipsychotic (SGA) drugs have been associated with
weight gain, hyperglycemia, and dyslipidemia. We evaluated whether glucose and lipid …

Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes.

EH Morrato, JW Newcomer, S Kamat, O Baser… - Diabetes Care, 2009 - go.gale.com
OBJECTIVE--Several second-generation antipsychotic (SGA) drugs have been associated
with weight gain, hyperglycemia, and dyslipidemia. We evaluated whether glucose and lipid …

Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes

EH Morrato, JW Newcomer, S Kamat… - Diabetes …, 2009 - pubmed.ncbi.nlm.nih.gov
Objective Several second-generation antipsychotic (SGA) drugs have been associated with
weight gain, hyperglycemia, and dyslipidemia. We evaluated whether glucose and lipid …

Metabolic Screening After the American Diabetes Association's Consensus Statement on Antipsychotic Drugs and Diabetes'

EH Morrato, JW Newcomer, S Kamat, O Baser… - Diabetes …, 2009 - search.proquest.com
Several second-generation antipsychotic (SGA) drugs have been associated with weight
gain, hyperglycemia, and dyslipidemia. We evaluated whether glucose and lipid testing …

Metabolic Screening After the American Diabetes Association's Consensus Statement on Antipsychotic Drugs and Diabetes

EH Morrato, JW Newcomer, S Kamat, O Baser… - Diabetes Care, 2009 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> OBJECTIVE</jats: title>< jats: p> Several second-generation
antipsychotic (SGA) drugs have been associated with weight gain, hyperglycemia, and …